Somnomed Ltd
ASX:SOM

Watchlist Manager
Somnomed Ltd Logo
Somnomed Ltd
ASX:SOM
Watchlist
Price: 0.46 AUD -2.13% Market Closed
Market Cap: 99.4m AUD
Have any thoughts about
Somnomed Ltd?
Write Note

Wall Street
Price Targets

SOM Price Targets Summary
Somnomed Ltd

Wall Street analysts forecast SOM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SOM is 0.46 AUD with a low forecast of 0.46 AUD and a high forecast of 0.48 AUD.

Lowest
Price Target
0.46 AUD
0% Downside
Average
Price Target
0.46 AUD
1% Upside
Highest
Price Target
0.48 AUD
4% Upside
Somnomed Ltd Competitors:
Price Targets
SIBN
SI-BONE Inc
75% Upside
IPD
ImpediMed Ltd
179% Upside
ABT
Abbott Laboratories
16% Upside
SHL
Siemens Healthineers AG
15% Upside
FPH
Fisher & Paykel Healthcare Corporation Ltd
5% Downside
SRT
Sartorius AG
68% Upside
MDT
Medtronic PLC
19% Upside
7733
Olympus Corp
32% Upside

Revenue
Forecast

Revenue Estimate
Somnomed Ltd

For the last 8 years the compound annual growth rate for Somnomed Ltd's revenue is 10%. The projected CAGR for the next 3 years is 12%.

10%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Somnomed Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat

Net Income
Forecast

Net Income Estimate
Somnomed Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-63%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SOM's stock price target?
Price Target
0.46 AUD

According to Wall Street analysts, the average 1-year price target for SOM is 0.46 AUD with a low forecast of 0.46 AUD and a high forecast of 0.48 AUD.

What is Somnomed Ltd's Revenue forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Somnomed Ltd's revenue is 10%. The projected CAGR for the next 3 years is 12%.

Back to Top